Advertisement

62nd ASH Annual Meeting & Exposition

The 62nd American Society of Hematology (ASH) Annual Meeting & Exposition will be all virtual this year, taking place Dec. 2-11. The meeting offers a comprehensive hematology educational experience and publishes thousands of scientific abstracts highlighting the latest findings in hematology.

This email series will provide coverage of the meeting, including:

  • Cost effectiveness of a triplet versus doublet therapy for multiple myeloma.
  • Health care resource utilization for a novel CAR T-cell therapy.
  • Pegcetacoplan versus eculizumab for patients with paroxysmal nocturnal hemoglobinuria.
  • Comorbidities and frailty in older adults with chronic lymphocytic leukemia.
  • New treatment combinations in multiple myeloma.

Keep an eye out for coverage of the meeting, and click here to learn more about ASH 2020.

Advertisement

Quick Links

Advertisement